BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 28179523)

  • 1. Progesterone-Based Contraceptives Reduce Adaptive Immune Responses and Protection against Sequential Influenza A Virus Infections.
    Hall OJ; Nachbagauer R; Vermillion MS; Fink AL; Phuong V; Krammer F; Klein SL
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28179523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential Infection in Ferrets with Antigenically Distinct Seasonal H1N1 Influenza Viruses Boosts Hemagglutinin Stalk-Specific Antibodies.
    Kirchenbaum GA; Carter DM; Ross TM
    J Virol; 2016 Jan; 90(2):1116-28. PubMed ID: 26559834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines.
    Dong W; Bhide Y; Sicca F; Meijerhof T; Guilfoyle K; Engelhardt OG; Boon L; de Haan CAM; Carnell G; Temperton N; de Vries-Idema J; Kelvin D; Huckriede A
    Front Immunol; 2018; 9():2312. PubMed ID: 30356772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 17β-estradiol protects females against influenza by recruiting neutrophils and increasing virus-specific CD8 T cell responses in the lungs.
    Robinson DP; Hall OJ; Nilles TL; Bream JH; Klein SL
    J Virol; 2014 May; 88(9):4711-20. PubMed ID: 24522912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal Introduction of Fc-Fused Interleukin-7 Provides Long-Lasting Prophylaxis against Lethal Influenza Virus Infection.
    Kang MC; Choi DH; Choi YW; Park SJ; Namkoong H; Park KS; Ahn SS; Surh CD; Yoon SW; Kim DJ; Choi JA; Park Y; Sung YC; Lee SW
    J Virol; 2015 Dec; 90(5):2273-84. PubMed ID: 26656713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR2 Regulates Vaccine-Induced Mucosal T-Cell Memory to Influenza A Virus.
    Lee W; Kingstad-Bakke B; Kedl RM; Kawaoka Y; Suresh M
    J Virol; 2021 Jul; 95(15):e0053021. PubMed ID: 33952647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mosaic H5 Hemagglutinin Provides Broad Humoral and Cellular Immune Responses against Influenza Viruses.
    Kamlangdee A; Kingstad-Bakke B; Osorio JE
    J Virol; 2016 Aug; 90(15):6771-6783. PubMed ID: 27194759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase-9 deficiency protects mice from severe influenza A viral infection.
    Rojas-Quintero J; Wang X; Tipper J; Burkett PR; Zuñiga J; Ashtekar AR; Polverino F; Rout A; Yambayev I; Hernández C; Jimenez L; Ramírez G; Harrod KS; Owen CA
    JCI Insight; 2018 Dec; 3(24):. PubMed ID: 30568032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virus-neutralizing antibody response of mice to consecutive infection with human and avian influenza A viruses.
    Janulíková J; Stropkovská A; Bobišová Z; Košík I; Mucha V; Kostolanský F; Varečková E
    Acta Virol; 2015 Jun; 59(2):166-73. PubMed ID: 26104333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of the NOD-Like Receptor NLRC5 Results in Decreased CD8
    Lupfer CR; Stokes KL; Kuriakose T; Kanneganti TD
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28615208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The magnitude of the T cell response to a clinically significant dose of influenza virus is regulated by TRAIL.
    Brincks EL; Gurung P; Langlois RA; Hemann EA; Legge KL; Griffith TS
    J Immunol; 2011 Nov; 187(9):4581-8. PubMed ID: 21940678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ataxia-telangiectasia mutated is required for the development of protective immune memory after influenza A virus infection.
    Warren R; Domm W; Yee M; Campbell A; Malone J; Wright T; Mayer-Pröschel M; O'Reilly MA
    Am J Physiol Lung Cell Mol Physiol; 2019 Nov; 317(5):L591-L601. PubMed ID: 31509427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Monoclonal Antibody 81.39a Effectively Neutralizes Emerging Influenza A Viruses of Group 1 and 2 Hemagglutinins.
    Marjuki H; Mishin VP; Chai N; Tan MW; Newton EM; Tegeris J; Erlandson K; Willis M; Jones J; Davis T; Stevens J; Gubareva LV
    J Virol; 2016 Dec; 90(23):10446-10458. PubMed ID: 27630240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory and systemic humoral and cellular immune responses of pigs to a heterosubtypic influenza A virus infection.
    Heinen PP; de Boer-Luijtze EA; Bianchi ATJ
    J Gen Virol; 2001 Nov; 82(Pt 11):2697-2707. PubMed ID: 11602782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-walled carbon nanotubes modulate pulmonary immune responses and increase pandemic influenza a virus titers in mice.
    Chen H; Zheng X; Nicholas J; Humes ST; Loeb JC; Robinson SE; Bisesi JH; Das D; Saleh NB; Castleman WL; Lednicky JA; Sabo-Attwood T
    Virol J; 2017 Dec; 14(1):242. PubMed ID: 29273069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profound protection against respiratory challenge with a lethal H7N7 influenza A virus by increasing the magnitude of CD8(+) T-cell memory.
    Christensen JP; Doherty PC; Branum KC; Riberdy JM
    J Virol; 2000 Dec; 74(24):11690-6. PubMed ID: 11090168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Immune Responses to and Cross-Protective Efficacy of Eurasian H7 Avian Influenza Viruses.
    Kwon HI; Kim YI; Park SJ; Song MS; Kim EH; Kim SM; Si YJ; Lee IW; Song BM; Lee YJ; Yun SJ; Kim WJ; Choi YK
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coinfection with SARS-CoV-2 and Influenza A Virus Increases Disease Severity and Impairs Neutralizing Antibody and CD4
    Kim EH; Nguyen TQ; Casel MAB; Rollon R; Kim SM; Kim YI; Yu KM; Jang SG; Yang J; Poo H; Jung JU; Choi YK
    J Virol; 2022 Mar; 96(6):e0187321. PubMed ID: 35107382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermediate Levels of Pre-Existing Protective Antibody Allow Priming of Protective T Cell Immunity against Influenza.
    Ng T; Flores-Malavet V; Mansoor MAM; Arvelo AC; Dhume K; Prokop E; McKinstry KK; Strutt TM
    J Immunol; 2023 Mar; 210(5):628-639. PubMed ID: 36645384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.